期刊文献+

Kelp Fucoidans Facilitate Vascular Recanalization via Inhibiting Excessive Activation of Platelet in Deep Venous Thrombosis Model of Mouse

下载PDF
导出
摘要 This study was carried out explore the mechanism underlying the inhibition of platelet activation by kelp fucoidans in deep venous thrombosis(DVT)mouse.In the control and sham mice,the walls of deep vein were regular and smooth with intact intima,myometrium and adventitia.The blood vessel was wrapped with the tissue and there was no thrombosis in the lumen.In the DVT model,the wall was uneven with thicken intima,myometrium and adventitia.After treated with fucoidans LF1 and LF2,the thrombus was dissolved and the blood vessel was recanalized.Compared with the control group,the ROS content,ET-1 and VWF content and the expression of PKC-βand NF-κB in the model were significantly higher(P<0.05);these levels were significantly reduced following treatments with LF2 and LF1.Compared with H_(2)O_(2)treated-HUVECs,combined LF1 and LF2 treatment resulted in significant decrease in the expression of PKC-β,NF-κB,VWF and TM protein(P<0.05).It is clear that LF1 and LF2 reduces DVT-induced ET-1,VWF and TM expressions and production of ROS,thus inhibiting the activation of PKC-β/NF-κB signal pathway and the activation of coagulation system and ultimately reducing the formation of venous thrombus.
出处 《Journal of Ocean University of China》 CAS CSCD 2024年第2期550-556,共7页 中国海洋大学学报(英文版)
基金 supported by the Special Fund for Clinical Scientific Research of Shandong Medical Association(No.YXH2020ZX058).
  • 相关文献

参考文献2

二级参考文献24

  • 1魏毅君,段维勋,熊红燕,雷兰萍,杨阳,陈涛,金振晓.乌司他丁对中性粒细胞介导的内皮细胞损伤的抑制作用[J].中国体外循环杂志,2013,11(4):242-247. 被引量:5
  • 2STEIN P D, GOODMAN L R, HULL R D, et al. Diagnosis and management of isolated subsegmental pulmonary embolism: review and assessment of the options[J]. C/in Appl Thromb Hemost, 2012, 18(1 ):20-26.
  • 3XENOS E S, VARGAS H D, DAVENPORT D L. Association of blood transfusion and venous thromboembolism after colorectal cancer resection[J]. Thromb Res, 2012, 129(5):568-572.
  • 4SOOD V, LUKE C E, DEATRICK K B, et al. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism[J]. Thromb Haemost, 2010 104(6):1174-1183.
  • 5NEW S E, AIKAWA E. Cardiovascular calcification: an inflammatory disease[J]. CircJ, 2011, 75(6):1305-1313.
  • 6CHEN W, LI Z, BAI L, et al. NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target[J]. Front Biosci, 2011, 16:1172-1185.
  • 7BURTON-FREEMAN B. Postprandial metabolic events and fruit-derived phenolics: a review of the science[J]. BrJ Nutr, 2010, 104 Suppl 3: S1-S14.
  • 8KONES R. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective [J]. Drug Des Devel Ther, 2010, 4:383-413.
  • 9OBITSU Y, SHIGEMATSU H. Deep vein thrombosis in patients with cancer[J]. Gan To Kagaku Ryoho, 2009, 36(4):535-539.
  • 10MEDZHITOV R, SHEVACH E M, TRINCHIERI G. Highlights of 10 years of immunology in Nature Reviews Immunology[J]. Nat Rev Imrnunol, 2011, 11 (10):693-702.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部